CASI Pharmaceuticals (CASI) Q4 2025 Earnings

14NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.86
-0.71
-0.55
-0.4

Details

Expected EPS
-0.4
Actual EPS
-0.68
Surprise EPS
-0.28
Surprise Percent
+70%

Description

CASI Pharmaceuticals (CASI) has reported earnings of -0.68 per share for Q4 2025.

0 Comments

Share your thoughts